These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 34884696)

  • 61. Colorectal cancer defeating? Challenge accepted!
    Di Franco S; Todaro M; Dieli F; Stassi G
    Mol Aspects Med; 2014 Oct; 39():61-81. PubMed ID: 23927966
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Direct activation of Bmi1 by Twist1: implications in cancer stemness, epithelial-mesenchymal transition, and clinical significance.
    Wu KJ
    Chang Gung Med J; 2011; 34(3):229-38. PubMed ID: 21733352
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Concise Review: Stem Cells and Epithelial-Mesenchymal Transition in Cancer: Biological Implications and Therapeutic Targets.
    Sato R; Semba T; Saya H; Arima Y
    Stem Cells; 2016 Aug; 34(8):1997-2007. PubMed ID: 27251010
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Colon cancer stem cells.
    Ricci-Vitiani L; Fabrizi E; Palio E; De Maria R
    J Mol Med (Berl); 2009 Nov; 87(11):1097-104. PubMed ID: 19727638
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The dynamics of cancer stem cells.
    Hatina J
    Neoplasma; 2012; 59(6):700-7. PubMed ID: 22862171
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Profilin 2 promotes migration, invasion, and stemness of HT29 human colorectal cancer stem cells.
    Kim MJ; Lee YS; Han GY; Lee HN; Ahn C; Kim CW
    Biosci Biotechnol Biochem; 2015; 79(9):1438-46. PubMed ID: 25964982
    [TBL] [Abstract][Full Text] [Related]  

  • 67. SIRT1 promotes epithelial-mesenchymal transition and metastasis in colorectal cancer by regulating Fra-1 expression.
    Cheng F; Su L; Yao C; Liu L; Shen J; Liu C; Chen X; Luo Y; Jiang L; Shan J; Chen J; Zhu W; Shao J; Qian C
    Cancer Lett; 2016 Jun; 375(2):274-283. PubMed ID: 26975631
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The SOX17/miR-371-5p/SOX2 axis inhibits EMT, stem cell properties and metastasis in colorectal cancer.
    Li Y; Lv Z; He G; Wang J; Zhang X; Lu G; Ren X; Wang F; Zhu X; Ding Y; Liao W; Ding Y; Liang L
    Oncotarget; 2015 Apr; 6(11):9099-112. PubMed ID: 25868860
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Human colorectal CD24+ cancer stem cells are susceptible to epithelial-mesenchymal transition.
    Okano M; Konno M; Kano Y; Kim H; Kawamoto K; Ohkuma M; Haraguchi N; Yokobori T; Mimori K; Yamamoto H; Sekimoto M; Doki Y; Mori M; Ishii H
    Int J Oncol; 2014 Aug; 45(2):575-80. PubMed ID: 24858473
    [TBL] [Abstract][Full Text] [Related]  

  • 70. TUSC3 promotes colorectal cancer progression and epithelial-mesenchymal transition (EMT) through WNT/β-catenin and MAPK signalling.
    Gu Y; Wang Q; Guo K; Qin W; Liao W; Wang S; Ding Y; Lin J
    J Pathol; 2016 May; 239(1):60-71. PubMed ID: 27071482
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Thyroid cancer stem-like cells and epithelial-mesenchymal transition in thyroid cancers.
    Hardin H; Montemayor-Garcia C; Lloyd RV
    Hum Pathol; 2013 Sep; 44(9):1707-13. PubMed ID: 23528862
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Differential membranous E-cadherin expression, cell proliferation and O-GlcNAcylation between primary and metastatic nodal lesion in colorectal cancer.
    Jang TJ
    Pathol Res Pract; 2016 Feb; 212(2):113-9. PubMed ID: 26724145
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The Association Between Inflammation, Epithelial Mesenchymal Transition and Stemness in Colorectal Carcinoma.
    Briede I; Strumfa I; Vanags A; Gardovskis J
    J Inflamm Res; 2020; 13():15-34. PubMed ID: 32021376
    [TBL] [Abstract][Full Text] [Related]  

  • 74. ZnAs@SiO
    Huang Y; Zhou B; Luo H; Mao J; Huang Y; Zhang K; Mei C; Yan Y; Jin H; Gao J; Su Z; Pang P; Li D; Shan H
    Theranostics; 2019; 9(15):4391-4408. PubMed ID: 31285768
    [No Abstract]   [Full Text] [Related]  

  • 75. Putative stem cells and epithelial-mesenchymal transition revealed in sections of ovarian tumor in patients with serous ovarian carcinoma using immunohistochemistry for vimentin and pluripotency-related markers.
    Kenda Suster N; Smrkolj S; Virant-Klun I
    J Ovarian Res; 2017 Feb; 10(1):11. PubMed ID: 28231820
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Notch-1 promotes stemness and epithelial to mesenchymal transition in colorectal cancer.
    Fender AW; Nutter JM; Fitzgerald TL; Bertrand FE; Sigounas G
    J Cell Biochem; 2015 Nov; 116(11):2517-27. PubMed ID: 25914224
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Intestinal stem cells and the colorectal cancer microenvironment.
    Ong BA; Vega KJ; Houchen CW
    World J Gastroenterol; 2014 Feb; 20(8):1898-909. PubMed ID: 24587669
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Carcinoma-associated fibroblasts promote the stemness and chemoresistance of colorectal cancer by transferring exosomal lncRNA H19.
    Ren J; Ding L; Zhang D; Shi G; Xu Q; Shen S; Wang Y; Wang T; Hou Y
    Theranostics; 2018; 8(14):3932-3948. PubMed ID: 30083271
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Organoid modelling identifies that DACH1 functions as a tumour promoter in colorectal cancer by modulating BMP signalling.
    Hu X; Zhang L; Li Y; Ma X; Dai W; Gao X; Rao X; Fu G; Wang R; Pan M; Guo Q; Xu X; Zhou Y; Gao J; Zhang Z; Cai S; Peng J; Hua G
    EBioMedicine; 2020 Jun; 56():102800. PubMed ID: 32512510
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Visualization of epithelial-mesenchymal transition in an inflammatory microenvironment-colorectal cancer network.
    Ieda T; Tazawa H; Okabayashi H; Yano S; Shigeyasu K; Kuroda S; Ohara T; Noma K; Kishimoto H; Nishizaki M; Kagawa S; Shirakawa Y; Saitou T; Imamura T; Fujiwara T
    Sci Rep; 2019 Nov; 9(1):16378. PubMed ID: 31705021
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.